S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
NASDAQ:MRVI

Maravai LifeSciences News Headlines

$24.46
-1.82 (-6.93%)
(As of 01/21/2022 12:00 AM ET)
Add
Compare
Today's Range
$24.25
$26.29
50-Day Range
$24.46
$45.94
52-Week Range
$24.25
$63.55
Volume
1.92 million shs
Average Volume
1.69 million shs
Market Capitalization
$6.30 billion
P/E Ratio
23.52
Dividend Yield
N/A
Beta
0.04
Get Maravai LifeSciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for MRVI and its competitors with MarketBeat's FREE daily newsletter.

Media Mentions By Week

Maravai LifeSciences Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

MRVI
News Sentiment

0.31

0.41

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

MRVI Articles
This Week

6

1

MRVI Articles
Average Week



Maravai LifeSciences (NASDAQ:MRVI) News Headlines Today

SourceHeadline
finance.yahoo.com logoMaravai LifeSciences Announces Debt Repricing
finance.yahoo.com - January 20 at 6:26 PM
MarketBeat logoMaravai LifeSciences (NASDAQ:MRVI) Hits New 1-Year Low at $27.60
americanbankingnews.com - January 18 at 6:24 PM
finance.yahoo.com logoHere’s What Makes Maravai LifeSciences (MRVI) A Great Investment Choice
finance.yahoo.com - January 5 at 9:07 AM
finance.yahoo.com logoMaravai LifeSciences Announces Registration and Webcast Information for Upcoming R&D Day, to be Held on January 28, 2022
finance.yahoo.com - January 5 at 9:07 AM
finance.yahoo.com logoMaravai Lifesciences Stock Closes In Technical Benchmark, Hitting 80-Plus RS Rating
finance.yahoo.com - January 3 at 6:18 PM
finance.yahoo.com logoIs Maravai LifeSciences Holdings, Inc. (MRVI) Stock Outpacing Its Medical Peers This Year?
finance.yahoo.com - December 28 at 2:54 PM
finance.yahoo.com logoTop Biotech Stocks for Q1 2022
finance.yahoo.com - December 24 at 11:34 AM
nasdaq.com logoIs Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Worth US$41.2 Based On Its Intrinsic Value?
nasdaq.com - December 23 at 1:39 PM
finance.yahoo.com logoTimothy Plan Aggressive Growth Fund Buys Palo Alto Networks Inc, Maravai LifeSciences Holdings ...
finance.yahoo.com - December 19 at 7:21 AM
finance.yahoo.com logoMaravai LifeSciences Added to the Nasdaq Biotechnology Index
finance.yahoo.com - December 14 at 9:43 AM
finance.yahoo.com logoMaravai LifeSciences Announces Establishment of New Charitable Foundation
finance.yahoo.com - December 9 at 8:05 PM
finance.yahoo.com logoHedge Funds Are Coming Back To Maravai LifeSciences Holdings, Inc. (MRVI)
finance.yahoo.com - December 9 at 12:17 AM
finance.yahoo.com logoEarnings Estimates Moving Higher for Maravai LifeSciences Holdings, Inc. (MRVI): Time to Buy?
finance.yahoo.com - December 6 at 5:27 PM
finance.yahoo.com logoCan Maravai LifeSciences Holdings, Inc. (MRVI) Climb 25% to Reach the Level Wall Street Analysts Expect?
finance.yahoo.com - December 6 at 12:27 PM
finance.yahoo.com logoHas LabCorp (LH) Outpaced Other Medical Stocks This Year?
finance.yahoo.com - November 24 at 1:30 PM
nasdaq.com logoMaravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) Share Price Could Signal Some Risk
nasdaq.com - November 17 at 6:37 PM
finance.yahoo.com logoRisks To Shareholder Returns Are Elevated At These Prices For Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)
finance.yahoo.com - November 17 at 1:37 PM
finance.yahoo.com logoHow Much Upside is Left in Maravai LifeSciences (MRVI)? Wall Street Analysts Think 40%
finance.yahoo.com - November 15 at 1:56 PM
finance.yahoo.com logoMaravai LifeSciences Holdings, Inc. (MRVI) Q3 2021 Earnings Call Transcript
finance.yahoo.com - November 11 at 10:24 AM
finance.yahoo.com logoMaravai LifeSciences Reports Third Quarter Financial Results, Updates 2021 Financial Guidance and Provides Preliminary Revenue Guidance For 2022
finance.yahoo.com - November 10 at 6:20 PM
finance.yahoo.com logoNew England Biolabs® releases next generation HiScribe™ in vitro transcription kit, incorporating TriLink® Biotechnologies' CleanCap® technology for mRNA synthesis
finance.yahoo.com - November 8 at 2:50 PM
nasdaq.com logoMaravai LifeSciences Holdings Becomes Oversold (MRVI)
nasdaq.com - November 8 at 12:40 AM
finance.yahoo.com logoMaravai LifeSciences Announces November 2021 Investor Conference Schedule
finance.yahoo.com - November 2 at 9:40 AM
markets.businessinsider.com logoMaravai LifeSciences Holdings Inc Registered -A- hosts conference call for investors
markets.businessinsider.com - October 21 at 11:46 AM
finance.yahoo.com logoMaravai LifeSciences To Host Earnings Conference Call on Wednesday, November 10, 2021
finance.yahoo.com - October 13 at 7:41 PM
finance.yahoo.com logoDoes This Valuation Of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Imply Investors Are Overpaying?
finance.yahoo.com - October 7 at 2:41 PM
finance.yahoo.com logoMaravai LifeSciences Expands its Intellectual Property Portfolio with European Patent
finance.yahoo.com - October 7 at 8:38 AM
finance.yahoo.com logoTriLink BioTechnologies® Extends EyeGene Partnership for COVID-19 Vaccine Development in South Korea
finance.yahoo.com - October 4 at 11:29 AM
nasdaq.com logoMaravai LifeSciences Holdings is Now Oversold (MRVI)
nasdaq.com - October 1 at 6:20 PM
finance.yahoo.com logoMaravai Lifesciences Stock Gets IBD Stock Rating Upgrade
finance.yahoo.com - September 30 at 5:18 PM
fool.com logoMaravai LifeSciences Holdings, Inc.(MRVI)
fool.com - September 17 at 12:48 AM
finance.yahoo.com logoMaravai Lifesciences Sees Composite Rating Move Up To 96
finance.yahoo.com - September 16 at 7:48 PM
finance.yahoo.com logoWhy Maravai LifeSciences Tumbled Nearly 12% Today
finance.yahoo.com - September 10 at 9:05 PM
finance.yahoo.com logoMaravai LifeSciences Announces Pricing of Secondary Offering of Class A Common Stock by Selling Stockholders
finance.yahoo.com - September 10 at 9:23 AM
bizjournals.com logoThompson Street Capital Partners acquires life science business Vector Laboratories
bizjournals.com - September 8 at 4:32 PM
finance.yahoo.com logoDow Jones Off Lows After Stock Market Sell-Off Fueled By Fed Official's Comments
finance.yahoo.com - September 8 at 4:32 PM
finance.yahoo.com logoStock Market Lower As These Leaders Slide; Beige Book Finds Slower Growth
finance.yahoo.com - September 8 at 4:32 PM
ca.finance.yahoo.com logoThompson Street Capital Partners Acquires Vector Laboratories
ca.finance.yahoo.com - September 7 at 9:11 AM
finance.yahoo.com logoMaravai LifeSciences Announces September 2021 Investor Conference Schedule
finance.yahoo.com - September 7 at 9:11 AM
seekingalpha.com logoMaravai LifeSciences Holdings, Inc. 2021 Q2 - Results - Earnings Call Presentation
seekingalpha.com - August 11 at 8:05 PM
fool.com logoMaravai LifeSciences Holdings, Inc. (MRVI) Q2 2021 Earnings Call Transcript
fool.com - August 10 at 10:56 PM
fool.com logoMaravai LifeSciences Holdings, Inc. (MRVI) Q2 2021 Earnings Call Transcript
fool.com - August 10 at 10:56 PM
finance.yahoo.com logoMaravai Lifesciences Reports Second Quarter Financial Results and Updates 2021 Financial Guidance
finance.yahoo.com - August 10 at 6:58 PM
finance.yahoo.com logoMaravai Lifesciences Shows Rising Relative Strength During Breakout
finance.yahoo.com - August 5 at 4:50 PM
finance.yahoo.com logoBiotech Maravai LifeSciences Sees RS Rating Rise To 89
finance.yahoo.com - August 4 at 10:46 PM
benzinga.com logoMaravai LifeSciences' TriLink BioTech Reports Extended Its Global Support Of COVID-19 Vaccine Development Into Asia Pacific Region
benzinga.com - August 3 at 10:08 AM
finance.yahoo.com logoTriLink BioTechnologies® Extends Global Support of Covid-19 Vaccine Development into APAC Region with the Chula Vaccine Research Center (Chula VRC), Bangkok
finance.yahoo.com - August 2 at 11:05 PM
finance.yahoo.com logoMaravai Lifesciences Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating
finance.yahoo.com - July 23 at 6:03 PM
finance.yahoo.com logoMaravai LifeSciences To Host Earnings Conference Call on Tuesday, August 10, 2021
finance.yahoo.com - July 20 at 5:42 PM
finance.yahoo.com logoMaravai Lifesciences Gets RS Rating Upgrade, Hitting 70+
finance.yahoo.com - July 20 at 12:42 PM
Get Maravai LifeSciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for MRVI and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 1/22/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.